Published in Ugeskr Laeger on May 15, 1995
Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice. Arterioscler Thromb Vasc Biol (2001) 2.62
Percutaneous transluminal coronary angioplasty versus thrombolysis in acute myocardial infarction. Scand Cardiovasc J (2000) 2.03
Gains and losses of warfarin therapy as performed in an anticoagulation clinic. J Intern Med (2006) 2.02
Evaluation of a near-patient test for C-reactive protein used in daily routine in primary healthcare by use of difference plots. Clin Chem (1997) 1.67
[From science to clinical practice. Risk assessment in relation to treatment and prevention]. Ugeskr Laeger (1999) 1.39
Near-patient test for C-reactive protein in general practice: assessment of clinical, organizational, and economic outcomes. Clin Chem (1999) 1.28
Telemedicine used for remote prehospital diagnosing in patients suspected of acute myocardial infarction. J Intern Med (2002) 1.23
Silent pulmonary embolism in patients with deep venous thrombosis. Incidence and fate in a randomized, controlled trial of anticoagulation versus no anticoagulation. J Intern Med (1994) 1.20
Junctional ectopic tachycardia after surgery for congenital heart disease in children. Intensive Care Med (2008) 1.19
Long-term therapy of arterial hypertension with nifedipine given alone or in combination with a beta-adrenoceptor blocking agent. Eur J Clin Pharmacol (1982) 1.17
Tissue injury and the inflammatory response to pediatric cardiac surgery with cardiopulmonary bypass: a descriptive study. Anesthesiology (2001) 1.14
Improvement in growth, and levels of insulin-like growth factor-I in the serum, after cavopulmonary connections. Cardiol Young (2000) 1.13
HbAlc in an unselected population of 4438 people with type 2 diabetes in a Danish county. Scand J Prim Health Care (2001) 1.11
Anticoagulant therapy in deep venous thrombosis. A randomized controlled study. Thromb Res (1994) 1.06
Prevention of postoperative deep venous thrombosis. Low-dose heparin versus graded pressure stockings. Acta Chir Scand (1985) 1.05
Primary PCI as the preferred reperfusion therapy in STEMI: it is a matter of time. Heart (2009) 1.04
Urinary retention during i.m. and extradural morphine analgesia. Br J Anaesth (1982) 1.03
Severe intoxication after an intentional overdose of amlodipine. Acta Anaesthesiol Scand (2003) 1.03
178 fatal cases of pulmonary embolism in a medical department. Acta Med Scand (1981) 0.97
Electromechanical mapping for detection of myocardial viability in patients with ischemic cardiomyopathy. Circulation (2001) 0.96
Graphical interpretation of analytical data from comparison of a field method with reference method by use of difference plots. Clin Chem (1997) 0.95
Use and validation of public data files for identification of the diabetic population in a Danish county. Dan Med Bull (2001) 0.93
Plaque pathology and coronary thrombosis in the pathogenesis of acute coronary syndromes. Scand J Clin Lab Invest Suppl (1999) 0.90
Cardiopulmonary bypass elicits a pro- and anti-inflammatory cytokine response and impaired neutrophil chemotaxis in neonatal pigs. Acta Anaesthesiol Scand (2001) 0.90
[Cross-sectional therapeutic programs--an example of a cooperative health care system. A review with comments]. Ugeskr Laeger (1998) 0.89
C-reactive protein in general practice--how commonly is it used and why? Scand J Prim Health Care (1997) 0.87
Systemic availability of acetylsalicylic acid in normal men and women and its effect on in vitro platelet aggregability. Eur J Clin Pharmacol (1983) 0.87
Increased blood loss after preoperative NSAID. Retrospective study of 186 hip arthroplasties. Acta Orthop Scand (1993) 0.86
Magnesium inhibits platelet activity--an in vitro study. Thromb Haemost (1996) 0.86
Magnesium inhibits platelet activity--an infusion study in healthy volunteers. Thromb Haemost (1996) 0.86
Doxazosin treatment in patients with prostatic obstruction. A double-blind placebo-controlled study. Scand J Urol Nephrol (1993) 0.85
Acute valproate intoxication: biochemical investigations and hemodialysis treatment. Int J Clin Pharmacol Ther Toxicol (1983) 0.85
Quality of lipid-lowering therapy in patients with ischaemic heart disease: a register-based study in 3477 patients. J Intern Med (2004) 0.84
Neurohormonal activation late after cavopulmonary connection. Heart (2000) 0.84
Platelet activity and in vivo arterial thrombus formation in rats with mild hyperhomocysteinaemia. Blood Coagul Fibrinolysis (2002) 0.83
[Diagnostic value of C-reactive protein in bacterial infections. Review of the literature]. Ugeskr Laeger (1998) 0.83
Low dose acetylsalicylic acid in the antithrombotic treatment of patients with stable angina pectoris and acute coronary syndromes (unstable angina pectoris and acute myocardial infarction). Pharmacol Toxicol (1994) 0.83
[Liver and kidney function in stainless steel welders]. Ugeskr Laeger (1981) 0.82
Myocardial infarction centres: the way forward. Heart (2005) 0.82
Improved nutritional status in elderly patients 6 months after stroke. J Nutr Health Aging (2007) 0.81
Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease. Scand J Gastroenterol (1998) 0.81
Urgent reversal of vitamin K antagonist therapy. Acta Anaesthesiol Scand (2011) 0.81
Systemic availability of acetylsalicylic acid in human subjects after oral ingestion of three different formulations. Acta Pharmacol Toxicol (Copenh) (1982) 0.80
Atherosclerosis and acute coronary events. Am J Cardiol (1998) 0.80
Effect of anticoagulant therapy on the hypercoagulable state in patients carrying the factor V Arg506Gln mutation. Thromb Res (1998) 0.80
Inhibition of nitric oxide synthesis improves left ventricular contractility in neonatal pigs late after cardiopulmonary bypass. Heart (1999) 0.80
Early administration of intravenous magnesium inhibits arterial thrombus formation. Arterioscler Thromb Vasc Biol (1997) 0.80
Pulmonary endothelial dysfunction after cardiopulmonary bypass in neonatal pigs. Acta Anaesthesiol Scand (2002) 0.79
The pharmacokinetics of frusemide are influenced by age. Br J Clin Pharmacol (1983) 0.79
The effect of changing excitation frequency on parallel conductance in different sized hearts. Cardiovasc Res (1998) 0.79
Intravenous magnesium does not influence the activity of the coagulation cascade. Blood Coagul Fibrinolysis (2001) 0.79
[Anticoagulant treatment]. Ugeskr Laeger (2000) 0.78
Stress response and platelet function in minor surgery during epidural bupivacaine and general anaesthesia: effect of epidural morphine addition. Eur J Anaesthesiol (1989) 0.78
Should patients with acute ST elevation MI be transferred for primary PCI? Heart (2004) 0.78
[Fatal pulmonary embolism in a medical department. Clinic-pathological correlations and therapeutic deliberations]. Ugeskr Laeger (1981) 0.78
From science to everyday clinical practice. Need for systematic evaluation of research findings. Scand J Prim Health Care (1999) 0.78
Intravenously and topically applied magnesium in the prevention of arterial thrombosis. Thromb Res (2000) 0.78
Platelet-derived growth factor release and antiplatelet treatment with low-dose acetylsalicylic acid. Angiology (1993) 0.78
Heparin-induced increase in serum levels of aminotranferases. A controlled clinical trial. Acta Med Scand (1984) 0.77
Magnesium inhibits human platelets. Blood Coagul Fibrinolysis (1996) 0.77
The influence of age on renal and extrarenal effects of frusemide. Br J Clin Pharmacol (1984) 0.77
The Arg506Gln mutation (FV Leiden) among a cohort of 4188 unselected Danish newborns. Thromb Res (1998) 0.77
Incomplete thromboxane inhibition with 100 mg of intravenous acetylsalicylic acid in patients with acute ST elevation myocardial infarction: a placebo-controlled pilot trial. Thromb Res (2001) 0.77
Dual inhibitory action of ATP on adrenergic neuroeffector transmission in rabbit pulmonary artery. Acta Pharmacol Toxicol (Copenh) (1985) 0.77
Topographic variations in alpha-adrenergic and cholinergic response in the pig renal pelvis. Urol Int (1983) 0.77
Plasma cytokines do not reflect expression of pro- and anti-inflammatory cytokine mRNA at organ level after cardiopulmonary bypass in neonatal pigs. Acta Anaesthesiol Scand (2003) 0.77
A randomized controlled trial of shared care versus routine care for patients receiving oral anticoagulant therapy. J Intern Med (2002) 0.77
Insights into the pathophysiology of unstable coronary artery disease. Am J Cardiol (1997) 0.76
Evaluation of a simple dosage scheme for transition from phenprocoumon to warfarin in oral anticoagulation. Thromb Res (2000) 0.75
The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction. J Intern Med (2004) 0.75
Beyond survival. Acta Anaesthesiol Scand (2013) 0.75
[Factor V Leiden mutation]. Ugeskr Laeger (1996) 0.75
Deep vein thrombosis detection by 99mTc-plasmin test and phlebography. Br J Surg (1984) 0.75
[Acetylsalicylic acid therapy and vascular surgery]. Ugeskr Laeger (1994) 0.75
Prazosin treatment of neurological patients with detrusor hyperreflexia and bladder emptying disability. Scand J Urol Nephrol (1989) 0.75
Are we underestimating the full potential of early thrombolytic treatment in patients with acute myocardial infarction? Heart (2003) 0.75
Dietary fish oil reduces microvascular thrombosis in a porcine experimental model. Thromb Res (2000) 0.75
Renal effects of chronic exposure to organic solvents. A clinical controlled trial. Acta Med Scand (1985) 0.75
[The value of anticoagulant therapy in deep venous thrombosis]. Ugeskr Laeger (1981) 0.75
[Diagnosis and treatment of pulmonary embolism in Denmark. A questionnaire study]. Ugeskr Laeger (1984) 0.75
[Severe poisoning with thyroid hormones in a body builder]. Ugeskr Laeger (1983) 0.75
[Pulmonary embolism. A diagnostic and therapeutic dilemma]. Ugeskr Laeger (1983) 0.75
Renal effects of acute exposure to toluene. A controlled clinical trial. Acta Med Scand (1985) 0.75
[Heparin-induced increase in serum aminotransferase]. Ugeskr Laeger (1984) 0.75
[The value of 99mTc-plasmin scanning in deep venous thrombosis]. Ugeskr Laeger (1984) 0.75
The influence of intravenous furosemide on the renal excretion pattern of protein and protein degradation products. Acta Pharmacol Toxicol (Copenh) (1984) 0.75
[Minoxidil (Lonoten)]. Ugeskr Laeger (1982) 0.75
[Acebutolol (Diasectral)]. Ugeskr Laeger (1983) 0.75
[Terodiline (Mictrol)]. Ugeskr Laeger (1987) 0.75
[The present status regarding the preventive treatment of deep venous thromboembolism]. Ugeskr Laeger (1985) 0.75
A new automated technique for platelet aggregation measurement. Scand J Clin Lab Invest (1984) 0.75
[Acetylsalicylic acid and renal damage. Evaluation of the role of acetylsalicylic acid in the development of analgesic nephropathy]. Ugeskr Laeger (1983) 0.75
Acute effects of acetylsalicylic acid on renal and hepatic function in normal humans. Int J Clin Pharmacol Ther Toxicol (1985) 0.75
Paediatric ECMO at low-volume paediatric cardiac centres in the Nordic countries. Acta Anaesthesiol Scand (2015) 0.75
[Acetylsalicylic acid in plasma after oral administration]. Ugeskr Laeger (1982) 0.75
[Prevention of postoperative venous thrombosis. A comparison between low-dose heparin and graduated compression stockings]. Ugeskr Laeger (1985) 0.75
[Employment of calcium antagonists in extracardial diseases]. Ugeskr Laeger (1986) 0.75